• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alcohols

Introduction to [3-(1H-Pyrazol-1-ylmethyl)phenyl]methanol (CAS No. 78425-12-4)

[3-(1H-Pyrazol-1-ylmethyl)phenyl]methanol is a significant compound in the field of pharmaceutical chemistry, known for its unique structural properties and potential applications in drug development. This compound, identified by the CAS number 78425-12-4, has garnered attention due to its role as a key intermediate in synthesizing various bioactive molecules. The presence of a pyrazole moiety and a phenyl ring linked by a methanol group makes it a versatile building block for medicinal chemists.

The pyrazole scaffold is particularly noteworthy in medicinal chemistry due to its prevalence in biologically active compounds. Pyrazole derivatives are known for their broad spectrum of pharmacological activities, including anti-inflammatory, antimicrobial, and antiviral properties. The incorporation of the pyrazole ring into [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol enhances its potential as a pharmacophore, making it a valuable candidate for further exploration in drug discovery.

In recent years, there has been a surge in research focusing on developing novel therapeutic agents with improved efficacy and reduced side effects. [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol has emerged as a compound of interest in this context. Its structural features allow for modifications that can fine-tune its biological activity, making it adaptable for various therapeutic targets. For instance, studies have shown that derivatives of this compound exhibit promising effects in the treatment of neurological disorders and cancer.

The synthesis of [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol involves multi-step organic reactions that highlight the compound's synthetic utility. The process typically begins with the condensation of pyrazole with appropriate phenolic precursors, followed by functional group transformations to introduce the methanol moiety. These synthetic pathways are well-documented and provide a solid foundation for further chemical modifications.

One of the most exciting aspects of [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol is its potential in developing targeted therapies. The combination of the pyrazole ring and the phenyl group creates a molecular framework that can interact with specific biological targets. This property is particularly valuable in oncology, where precision targeting is crucial for effective cancer treatment. Recent studies have demonstrated that compounds structurally similar to [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol can inhibit the growth of certain cancer cell lines by interfering with key signaling pathways.

The pharmacokinetic properties of [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol are also an area of active investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its therapeutic potential. Preliminary studies suggest that it exhibits favorable pharmacokinetic profiles, which could make it suitable for oral administration. However, further research is needed to fully characterize these properties and ensure safety and efficacy.

In addition to its pharmaceutical applications, [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol has shown promise in other areas of chemical biology. Its ability to serve as a precursor for more complex molecules makes it useful in the synthesis of natural products and synthetic analogs. Researchers are exploring its use in developing new materials and catalysts that could have applications in industry and environmental science.

The future direction of research on [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol is likely to focus on expanding its therapeutic applications and understanding its mechanism of action at a molecular level. Advances in computational chemistry and high-throughput screening techniques will accelerate the discovery process, allowing researchers to rapidly identify new derivatives with enhanced properties. Collaborative efforts between academia and industry will be crucial in translating these findings into clinical reality.

In conclusion, [3-(1H-pyrazol-1-ylmethyl)phenyl]methanol (CAS No. 78425-12-4) is a versatile compound with significant potential in pharmaceutical research. Its unique structure, combined with its synthetic accessibility, makes it an attractive candidate for developing new drugs targeting various diseases. As research continues to uncover its biological activities and optimize its pharmacological properties, this compound is poised to play a crucial role in future medical advancements.

• 10199-67-4(N-Benzylpyrazole)
• 936940-11-3((1-Benzyl-1H-pyrazol-4-yl)methylamine)
• 160388-55-6(4-(1H-Pyrazol-1-ylmethyl)phenylmethanol)
• 80200-09-5(1-(4-hydroxybenzyl)pyrazole)
• 878466-22-9({2-(1H-pyrazol-1-yl)methylphenyl}methanamine)
• 904696-62-4(1-4-(Aminomethyl)benzyl-1H-pyrazole Hydrochloride)
• 160388-53-4(4-(1H-Pyrazol-1-ylmethyl)benzoic acid)
• 562803-76-3({3-(1H-Pyrazol-1-yl)methylphenyl}methylamine)
• 70817-17-3((1-BENZYL-1H-PYRAZOL-4-YL)METHANOL)
• 562803-68-3(3-(1H-Pyrazol-1-ylmethyl)benzoic Acid)